UK approves Pfizer and BioNTech’s COVID-19 vaccine for emergency use
The UK has become the first western country to approve Pfizer and BioNTech’s COVID-19 vaccine for emergency use. The United
Read more
Infectious Diseases
FDA approves Roche’s Xofluza for Influenza post-exposure prophylaxis
Roche has announced that the U.S. FDA has granted supplemental New Drug Application (sNDA) approval for Xofluza, the first single-dose
Read more
EC to purchase up to 160 mill doses of Moderna’s COVID-19 vaccine
Moderna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
Read more
Trial data shows AstraZeneca’s COVID-19 vaccine was highly effective
AstraZeneca announced today, that interim trial data has shown it’s COVID-19 vaccine candidate AZD1222, developed in collaboration with the University
Read more
Moderna’s COVID-19 vaccine shows efficacy of 94.5% in Phase 3 trial
Moderna announced its vaccine candidate against COVID-19 named mRNA-1273, has met Phase 3 study statistical criteria with a vaccine efficacy
Read more
CureVac’s COVID-19 Vaccine stable at standard refrigerator temperature
CureVac, a German biopharmaceutical company developing innovative medicines based on messenger ribonucleic acid (mRNA), announced that its mRNA-based COVID-19 vaccine
Read more
Cold chain supply challenges for Pfizer and BioNTech’s COVID-19 vaccine
Governments around the world are scrambling to prepare for the rollout of the Pfizer and BioNTech COVID-19 vaccine, with many
Read more
Pfizer & BioNTech to supply EU with 200 million COVID-19 vaccine doses
Pfizer and BioNTech announced this week that they have reached an agreement with the European Commission to supply 200 million
Read more
Pfizer and BioNTech announce important COVID-19 vaccine breakthrough
Pfizer and BioNTech have announced their mRNA-based vaccine candidate for COVID-19, tested in a Phase 3 study involving 43,538 participants,
Read more
Vaccine Manufacturing and R&D Facility, Novavax, Gaithersburg, Maryland
Novavax has announced the expansion of its Gaithersburg, Maryland campus to support global vaccine development through the addition of two
Read more